PERSPECTA

News from every angle

Back to headlines

Bosnia and Herzegovina Approves Controversial Drug Remifentanil for Use

Bosnia and Herzegovina's Commission for the Suppression of Drug Abuse has approved remifentanil for use, reclassifying it from a completely banned substance to one under strict supervision.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.